ReviewTherapeutic advances in hematology2022

The development of pevonedistat in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): hope or hype?

Anson Snow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.